Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model

Lade...
Vorschaubild
Dateien
Zhong_2-196deomaohfnu4.pdf
Zhong_2-196deomaohfnu4.pdfGröße: 5.22 MBDownloads: 307
Datum
2020
Autor:innen
Zhong, Xiali
Harris, Georgina
Smirnova, Lena
Zufferey, Valentin
de Cássia da Silveira e Sá, Rita
Baldino Russo, Fabiele
Baleeiro Beltrao Braga, Patricia Cristina
Chesnut, Megan
Pamies, David
et al.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
European Union (EU): 681002
Projekt
EUToxRisk21
Open Access-Veröffentlichung
Open Access Gold
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Frontiers in Cellular Neuroscience. Frontiers Research Foundation. 2020, 14, 25. eISSN 1662-5102. Available under: doi: 10.3389/fncel.2020.00025
Zusammenfassung

Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been raised about the possible effects of these drugs on fetal development. Current developmental neurotoxicity (DNT) testing conducted in rodents is expensive, time-consuming, and does not necessarily represent human pathophysiology. A human, in vitro testing battery to cover key events of brain development, could potentially overcome these challenges. In this study, we assess the DNT of paroxetine—a widely used SSRI which has shown contradictory evidence regarding effects on human brain development using a versatile, organotypic human induced pluripotent stem cell (iPSC)-derived brain model (BrainSpheres). At therapeutic blood concentrations, which lie between 20 and 60 ng/ml, Paroxetine led to an 80% decrease in the expression of synaptic markers, a 60% decrease in neurite outgrowth and a 40–75% decrease in the overall oligodendrocyte cell population, compared to controls. These results were consistently shown in two different iPSC lines and indicate that relevant therapeutic concentrations of Paroxetine induce brain cell development abnormalities which could lead to adverse effects.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
paroxetine, SSRI, organoid, neurotoxicity, developmental neurotoxicity, 3D, iPSC
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690ZHONG, Xiali, Georgina HARRIS, Lena SMIRNOVA, Valentin ZUFFEREY, Rita DE CÁSSIA DA SILVEIRA E SÁ, Fabiele BALDINO RUSSO, Patricia Cristina BALEEIRO BELTRAO BRAGA, Megan CHESNUT, Thomas HARTUNG, David PAMIES, 2020. Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model. In: Frontiers in Cellular Neuroscience. Frontiers Research Foundation. 2020, 14, 25. eISSN 1662-5102. Available under: doi: 10.3389/fncel.2020.00025
BibTex
@article{Zhong2020-02-21Antid-48821,
  year={2020},
  doi={10.3389/fncel.2020.00025},
  title={Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model},
  volume={14},
  journal={Frontiers in Cellular Neuroscience},
  author={Zhong, Xiali and Harris, Georgina and Smirnova, Lena and Zufferey, Valentin and de Cássia da Silveira e Sá, Rita and Baldino Russo, Fabiele and Baleeiro Beltrao Braga, Patricia Cristina and Chesnut, Megan and Hartung, Thomas and Pamies, David},
  note={Article Number: 25}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/48821">
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/48821/1/Zhong_2-196deomaohfnu4.pdf"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-02-26T10:29:14Z</dc:date>
    <dc:contributor>Zufferey, Valentin</dc:contributor>
    <dc:creator>Zufferey, Valentin</dc:creator>
    <dc:creator>Baldino Russo, Fabiele</dc:creator>
    <dc:creator>Baleeiro Beltrao Braga, Patricia Cristina</dc:creator>
    <dc:contributor>Hartung, Thomas</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Pamies, David</dc:creator>
    <dcterms:title>Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model</dcterms:title>
    <dc:contributor>Harris, Georgina</dc:contributor>
    <dc:contributor>Baldino Russo, Fabiele</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Baleeiro Beltrao Braga, Patricia Cristina</dc:contributor>
    <dcterms:abstract xml:lang="eng">Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been raised about the possible effects of these drugs on fetal development. Current developmental neurotoxicity (DNT) testing conducted in rodents is expensive, time-consuming, and does not necessarily represent human pathophysiology. A human, in vitro testing battery to cover key events of brain development, could potentially overcome these challenges. In this study, we assess the DNT of paroxetine—a widely used SSRI which has shown contradictory evidence regarding effects on human brain development using a versatile, organotypic human induced pluripotent stem cell (iPSC)-derived brain model (BrainSpheres). At therapeutic blood concentrations, which lie between 20 and 60 ng/ml, Paroxetine led to an 80% decrease in the expression of synaptic markers, a 60% decrease in neurite outgrowth and a 40–75% decrease in the overall oligodendrocyte cell population, compared to controls. These results were consistently shown in two different iPSC lines and indicate that relevant therapeutic concentrations of Paroxetine induce brain cell development abnormalities which could lead to adverse effects.</dcterms:abstract>
    <dc:creator>Chesnut, Megan</dc:creator>
    <dc:contributor>Pamies, David</dc:contributor>
    <dcterms:issued>2020-02-21</dcterms:issued>
    <dc:contributor>Zhong, Xiali</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:creator>de Cássia da Silveira e Sá, Rita</dc:creator>
    <dc:creator>Harris, Georgina</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-02-26T10:29:14Z</dcterms:available>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/48821/1/Zhong_2-196deomaohfnu4.pdf"/>
    <dc:contributor>Chesnut, Megan</dc:contributor>
    <dc:creator>Zhong, Xiali</dc:creator>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Smirnova, Lena</dc:contributor>
    <dc:creator>Hartung, Thomas</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Smirnova, Lena</dc:creator>
    <dc:contributor>de Cássia da Silveira e Sá, Rita</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/48821"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen